Sector Perspective Therapeutics, Inc.

Aandelen

CATX

US46489V3024

Biotechnologie & Medisch Onderzoek

Beurs gesloten - 22:00:00 01-10-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
2,720 USD -1,09% Intraday-grafiek van Perspective Therapeutics, Inc. +8,80% -1,09%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
-1,09%+8,80%-12,26%-21,39%-1,09%-20,70%-0,62%-57,03%-62,22% 310 mln.
+4,16%+3,04%+8,38%+33,66%+84,62%+49,37%+94,17%+9,52% - 74,41 mld.
-1,26%-1,68%-7,73%+0,70%+15,93%+24,25%+77,94%+224,10%+5.392,40% 59,26 mld.
+1,37%-0,46%-2,88%+0,35%+5,36%+4,46%+34,74%-17,91%+203,81% 47,14 mld.
-3,02%-5,20%+0,92%+28,31%+15,66%+27,94%+32,51%+7,94%+221,64% 42,91 mld.
+0,31%+3,02%-1,90%+9,80%+158,49%+348,95%+643,82%+607,04% - 44,13 mld.
-1,96%-0,33%+0,03%+23,40%+18,09%+7,04%+99,46%+0,58%+1.064,46% 40,79 mld.
+3,32%+3,49%-2,34%+5,21%+6,51%+10,10%+51,23%-9,95%+145,56% 30,77 mld.
-2,68%+2,92%+10,78%+52,12%+73,51%+29,63%+22,72%-52,81% - 29,31 mld.
-4,86%-10,66%-10,63%+1,49%-37,61%-26,27%+330,06%+296,60%+647,87% 23,71 mld.
-1,48%-2,43%-5,00%+3,12%+1,73%-5,24%-10,85%-61,99% - 24,33 mld.
-0,43%+1,10%+5,84%+22,84%+13,57%+13,68%-5,81%-15,46%+101,58% 20,81 mld.
-4,18%-3,63%+2,55%+10,03%+6,49%+9,96%+147,01%+205,72%+1.902,95% 16,69 mld.
-3,70%+1,30%-10,69%-4,57%+176,14%+132,17%+328,65%+1.700,34%+638,60% 15,17 mld.
-0,23%-1,47%-12,66%-15,12% - - - - - 14,93 mld.
-3,04%+1,11%-4,22%+0,98%+20,40%-16,05%+500,76% - - 14,84 mld.
+0,72%-3,00%+3,11%+8,53%+20,26%+19,41%+43,37%-28,37%+82,31% 14,57 mld.
-6,59%-6,98%+22,85%+24,19%+29,55%-13,06% - - - 13,8 mld.
-0,80%-0,02%+1,85%+7,38%+32,19%+40,63%+165,17%+168,99%+353,01% 14,36 mld.
-2,77%-2,58%+1,59%+25,20%+43,79%+68,25%+46,36%-31,16%+244,17% 13,69 mld.
Gemiddelde -1,01%-0,74%-0,62%+10,81%+35,98%+37,08%+144,48%+173,30%+841,24% 27,8 mld.
Gewogen gemiddelde per kap. -0,41%-0,73%+0,02%+14,80%+41,65%+48,92%+142,87%+145,30%+1.337,73%
  1. Beurs
  2. Aandelen
  3. Koers CATX
  4. Sector Perspective Therapeutics, Inc.